You just read:

Asterias Biotherapeutics Announces Dosing of First Patient in New SCiSTAR Clinical Trial Cohort Testing AST-OPC1 in an Expanded Cervical Spinal Cord Injury Patient Population

News provided by

Asterias Biotherapeutics, Inc.

Sep 27, 2016, 07:00 ET